Virtual
Event Title
Public Meeting on Patient-Focused Drug Development for Systemic Sclerosis
October 13, 2020
Event Title
Public Meeting on Patient-Focused Drug Development for Systemic Sclerosis
October 13, 2020
- Date:
- October 13, 2020
- Time:
-
10:00 AM - 2:30 PM ET
On October 13th, 2020, FDA hosted a virtual public meeting on Patient-Focused Drug Development for Systemic Sclerosis. FDA was interested in hearing patients’ perspectives on the impact of systemic sclerosis on daily life and patient views on treatment approaches.
Location:
VIRTUAL EVENT
Meeting Materials
Public Docket:
In addition to providing input at the public meeting, stakeholders are invited to provide their perspectives on the discussion questions through the public docket.
- The docket closes on December 15, 2020. FDA is interested in responses to the questions listed in the public docket.